ICH GCP Goes Risk-based

ICH GCP Goes Risk-based

By |2017-06-14T09:32:41+00:00June 14, 2017|Comments Off on ICH GCP Goes Risk-based

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Upcoming Events

  1. PCT Europe 2018

    November 28 - November 29

Register Today!

Get Free Test Access